Komori
Yuki Gosei Kogyo (4531) · PolicyAdvanced

Reviewing the Rationale for Cross-Shareholdings and Reducing Them

First written in FY2019. 6 of 8 entries say "Advanced", first in FY2020. Latest entry: 2026-09-18.

8entries
8years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019AdvancedFY2020 – FY2021-Q2RestatedFY2022AdvancedFY2024 – 2026-09-182019: 120192020: 320202021: 020212022: 120222023: 020232024: 120242025: 020252026: 22026
Same theme, other companies
Review of the Rationale for Holding Strategic ShareholdingsA theme 1258 companies write about · 1 as a headwind · 666 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1262 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-09-18AdvancedOccurring Fact

    「We sold the shares in order to reduce cross-shareholdings and improve asset efficiency.」

    Based on the policy of reducing cross-shareholdings, the company disclosed the specific execution of the sale of 4 listed securities between 18 June and 11 September 2026, recording a gain on sales of investment securities of ¥524 million.
  2. FY2026AdvancedAnnual report

    「(Holdings with a decrease in the number of shares during the current fiscal year) Shares other than unlisted shares 4 companies ¥113 million」

    For policy-held shares, the company continued its policy of reviewing rationale through the Board of Directors and reducing holdings, and sold shares in 4 companies during the current fiscal year, recording total sales proceeds of ¥113 million.
  3. FY2024AdvancedAnnual report

    「When newly acquiring shares, the company clarifies the purpose of the acquisition and regularly reviews the status of transactions and other matters after acquisition. If it determines that the shares are unlikely to contribute to stable and sustainable cash flows or to an increase in corporate value, it will reduce its holdings through such means as selling the shares. The appropriateness of holding policy-held shares is reviewed internally as appropriate and deliberated by the Board of Directors once a year.」

    For policy-held shares, the company sold shares in 1 company during the current fiscal year and recorded sales proceeds of ¥13 million. This adds a specific sale based on its rationale review and reduction policy.
  4. FY2022RestatedAnnual report

    「When newly acquiring shares, the company clarifies the purpose of the acquisition and regularly reviews the status of transactions and other matters after acquisition. If it determines that the shares are unlikely to contribute to stable and sustainable cash flows or to an increase in corporate value, it will reduce its holdings through such means as selling the shares. The appropriateness of holding policy-held shares is reviewed internally as appropriate and deliberated by the Board of Directors once a year.」

    For policy-held shares, the company continues its policy of clarifying acquisition purposes, conducting regular reviews, deliberating the matter at Board of Directors meetings once a year, and selling or reducing holdings when their rationale is weak. It disclosed that no holdings had decreased in number of shares during the current fiscal year.
  5. FY2021-Q2AdvancedAnnual report

    「Increase mainly from ¥106 million in proceeds from the sale of investment securities」

    In connection with its policy of reducing policy-held shares and other holdings, the company actually sold investment securities and recorded ¥106 million in proceeds. It also recorded ¥54 million in gains on sales of investment securities in the income statement, indicating a specific implementation stage following the policy and sales results through the previous fiscal year.
  6. FY2021-Q1AdvancedAnnual report

    「The company sold part of its investment securities during July and August 2020. In connection with this, it plans to record approximately ¥50 million in gains on sales of investment securities as extraordinary income for the second quarter of the fiscal year ending March 2021.」

    In connection with its policy of reducing policy-held shares and other holdings, the company is proceeding with the sale of part of its investment securities during July and August 2020. It plans to record approximately ¥50 million in gains on the sale in the second quarter, indicating a specific implementation stage following sales through the previous fiscal year.
  7. FY2020AdvancedAnnual report

    「Based on the Board of Directors' review, the company sold some of its holdings in the fiscal year ended March 2020.」

    For policy-held shares, based on the annual review by the Board of Directors, the company sold shares in 2 companies in the fiscal year ended March 2020, for total consideration of ¥184 million.
  8. FY2019First statedAnnual report

    「When newly acquiring shares, the company clarifies the purpose of the acquisition and regularly reviews the status of transactions and other matters after acquisition. If it determines that the shares are unlikely to contribute to stable and sustainable cash flows or to an increase in corporate value, it will reduce its holdings through such means as selling the shares. The appropriateness of holding policy-held shares is reviewed internally as appropriate and deliberated by the Board of Directors once a year. Based on the Board's review, the company sold some of its holdings in the fiscal year ended March 2019.」

    For policy-held shares, the company has disclosed for the first time a policy of clarifying the purpose of acquisitions, regularly reviewing transaction status, deliberating the matter at Board of Directors meetings once a year, and selling or reducing holdings when their rationale is weak. In the fiscal year ended March 2019, it actually sold shares in 1 company.
Moved together

"Putting Pharmaceutical Intermediates and APIs on a Growth Trajectory" moved the same way as this thread, in the same document, in 3 of its 8 moves.

322222★123456
  1. ★This thread
  2. 1Putting Pharmaceutical Intermediates and APIs on a Growth Trajectory3×
  3. 2Revitalizing and Rebuilding the Amino-Acid Business and Maintaining and Expanding Top Market Share Through Global Expansion2×
  4. 3Building an Organization Where Diverse Talent Can Thrive2×
  5. 4Balancing Retained Earnings with Stable Dividends2×
  6. 5Dependence on Major Customers2×
  7. 6Strengthening Workstyle Reform and Talent Development2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Yuki Gosei Kogyo's next results are scheduled for 2026-10-30. Read the earnings preview It last moved in the Occurring Fact of 2026-09-18: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Reviewing the Rationale for Cross-Shareholdings and Reducing Them | Yuki Gosei Kogyo Co.,Ltd. (4531) | Komori